These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [A study of neuroleptic malignant syndrome in the presenium and senium]. Suzuki I, Honma H, Watanabe N, Matsubara S, Koyama T. Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353 [Abstract] [Full Text] [Related]
10. [A case of neuroleptic malignant syndrome developed in liver cirrhosis patient addicted to alcohol]. Minamisawa S, Tezuka T, Enomoto K, Nozaki Y, Funatomi H, Hatta Y. Arukoru Kenkyuto Yakubutsu Ison; 1991 Oct; 26(5):367-72. PubMed ID: 1772376 [Abstract] [Full Text] [Related]
11. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?]. Weller M, Kornhuber J. Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832 [Abstract] [Full Text] [Related]
12. Haloperidol-induced neuroleptic malignant syndrome complicated by hyperosmolar hyperglycemic state. Rock W, Elias M, Lev A, Saliba WR. Am J Emerg Med; 2009 Oct; 27(8):1018.e1-3. PubMed ID: 19857430 [Abstract] [Full Text] [Related]
14. Electroconvulsive therapy for the treatment of neuroleptic malignant syndrome with psychotic symptoms: a report of five cases. Nisijima K, Ishiguro T. J ECT; 1999 Jun; 15(2):158-63. PubMed ID: 10378156 [Abstract] [Full Text] [Related]